Neurodegeneration – News and Features

A study from Arizona State University links glyphosate, a widely used herbicide, to Alzheimer’s-like brain damage and persistent neuroinflammation in mice. Findings show lasting effects even at regulatory "safe" doses.

A novel computational pipeline has been designed to identify protein biomarkers associated with complex diseases, including Alzheimer’s disease.

New discoveries that provide a deeper understanding of how Alzheimer's develops have emerged from spider brain research.

Researchers have discovered that the armlike structure of mammalian brain cells may be a different shape than previously thought.

Beta-blocker drugs commonly used to treat heart conditions may also slow the progression of Huntington's disease, a new study has found.

Deep brain stimulation to the lateral hypothalamus has improved lower limb movements in two people with partial spinal cord injury.

Researchers have identified that the SARS-CoV-2 spike protein accumulates in the brain's protective layers, potentially explaining the neurological symptoms of long COVID.

A pioneering technique, PRINCESS, prints the smallest human blood vessels to date, enabling realistic drug testing without animals. This offers a cost-effective, human-based model for drug screening and disease research.

A study has found that high cardiovascular risk factors, including obesity, are linked to accelerated brain volume loss, affecting the regions in the temporal lobe that are crucial for memory and sensory processing.

A new study confirms that an "Alzheimer's in a dish" model can mimic brain function and gene expression patterns, making it ideal for assessing new drugs as well as finding new targets.